Gleason Shane Thomas 4
4 · InspireMD, Inc. · Filed Feb 2, 2026
Research Summary
AI-generated summary of this filing
InspireMD (NSPR) CCO Shane Gleason Sells Shares
What Happened
Shane Gleason, Chief Commercial Officer of InspireMD (NSPR), reported ten open-market sales between Jan 15 and Feb 2, 2026, disposing of a total of 61,194 common shares for aggregate proceeds of approximately $99,330. Individual sales ranged from 2,000 to 17,593 shares at prices between $1.57 and $1.66 per share. These were sales (S) — not purchases — and were executed to cover tax withholding on vested restricted stock (see footnote).
Key Details
- Transaction dates & prices (summary): Jan 15–Feb 2, 2026; per-share prices ranged $1.57–$1.66. Proceeds by trade totaled roughly $4.6k, $3.6k, $4.7k, $28.6k, $13.2k, $8.0k, $20.5k, $8.3k, $4.7k and $3.2k respectively. Aggregate: 61,194 shares for ~$99,330.
- Shares owned after transaction: Not specified in this filing.
- Footnote: F1 states these were sell-to-cover transactions required to satisfy tax withholding arising from vesting of restricted stock; sales were per an automatic sell-to-cover instruction adopted Nov 25, 2024 and “do not represent discretionary trades.”
- Filing: Form 4 filed Feb 2, 2026 (transactions occurred Jan 15–Feb 2); earlier trades appear to fall outside the typical two-business-day Form 4 reporting window for officers, so check for any prior filings or explanatory amendments.
- Exhibit: 24.1 Power of Attorney attached.
Context
Sell-to-cover transactions are common when restricted stock vests and are routine tax-related dispositions; they generally should not be interpreted as a bullish or bearish signal about the company's prospects. The filing lists code S (sale) and footnote F (tax withholding).
Insider Transaction Report
- Sale
Common Stock
[F1]2026-01-15$1.58/sh−2,909$4,593→ 1,197,462 total - Sale
Common Stock
[F1]2026-01-16$1.61/sh−2,250$3,627→ 1,195,212 total - Sale
Common Stock
[F1]2026-01-20$1.59/sh−2,955$4,710→ 1,192,257 total - Sale
Common Stock
[F1]2026-01-21$1.62/sh−17,593$28,553→ 1,174,664 total - Sale
Common Stock
[F1]2026-01-22$1.57/sh−8,411$13,239→ 1,166,253 total - Sale
Common Stock
[F1]2026-01-27$1.66/sh−4,781$7,956→ 1,161,472 total - Sale
Common Stock
[F1]2026-01-28$1.65/sh−12,395$20,464→ 1,149,077 total - Sale
Common Stock
[F1]2026-01-29$1.65/sh−5,000$8,250→ 1,144,077 total - Sale
Common Stock
[F1]2026-01-30$1.63/sh−2,900$4,730→ 1,141,177 total - Sale
Common Stock
[F1]2026-02-02$1.60/sh−2,000$3,208→ 1,139,177 total
Footnotes (1)
- [F1]The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.